Advertisement

Picture EBD Group ChinaBio Partnerting Forum 2021 651x80

News > All

Please find below news from the United Kingdom (Great Britain) and the Republic of Ireland as well as about organisations from these countries.

Total search results: 2456 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page

order ascendingorder descendingSource order ascendingorder descendingDate
Sofinnova Partners. (3/3/21). "Press Release: Sofinnova Partners Closes €445M ($540M) Oversubscribed Late-stage Healthcare Crossover Fund". Paris. 2021-03-03
Dotmatics Ltd.. (3/3/21). "Press Release: Dotmatics Announces Licensing Agreement for Informatics Software with Compugen". Bishop’s Stortford. 2021-03-03
LGC. (3/3/21). "Press Release: LGC Acquires Paragon Scientific, Strengthening Its Position in Reference Materials". London. 2021-03-03
TrakCel Ltd.. (3/3/21). "Press Release: TrakCel Fuels Growth and Increased Market Access Through Strategic Investment Round". Cardiff. 2021-03-03
ERS Genomics Ltd.. (3/3/21). "Press Release: ERS Genomics Licenses CRISPR Gene Editing Technology to Otsuka Pharmaceutical". Dublin. 2021-03-03
ERS Genomics Ltd.. (3/1/21). "Press Release: ERS Genomics Expands Team With Appointment of Jon Kratochvil as VP Business Development". Dublin. 2021-03-01
Oxular Ltd.. (3/1/21). "Press Release: Oxular Raises $37 Million". Oxford. 2021-03-01
Nabriva Therapeutics plc. (2/26/21). "Press Release: Nabriva Therapeutics Appoints Daniel Dolan as Chief Financial Officer". Dublin & King of Prussia, PA. 2021-02-26
Coulter Partners. (2/25/21). "Press Release: Coulter Partners Announces New Appointments in London, the US and Germany". 2021-02-25
Aptum Biologics Ltd.. (2/24/21). "Press Release: New Features of EpiQuest Suite Software (v4)". Southampton. 2021-02-24
Resolve Biosciences GmbH. (2/22/21). "Press Release: Resolve Biosciences Announces Initial Results from Early Access Collaborations with Scientists Leading the Next Generation of Subcellular Spatial Analysis". Monheim am Rhein. 2021-02-22
Immunocore Holdings plc. (2/19/21). "Press Release: Immunocore’s Tebentafusp Granted Breakthrough Therapy Designation for Unresectable or Metastatic Uveal Melanoma from FDA". Oxfordshire, Conshohocken, PA & Rockville, MD. 2021-02-19
Evox Therapeutics Ltd.. (2/18/21). "Press Release: Evox Therapeutics Completes £69.2 Million Series C Financing". 2021-02-18
Charles River Laboratories International, Inc.. (2/17/21). "Press Release: Charles River Laboratories to Acquire Cognate BioServices to Create a Premier Scientific Partner for Cell and Gene Therapy Development". Wilmington, MA. 2021-02-17
ERS Genomics Ltd.. (2/16/21). "Press Release: ERS Genomics and ZeClinics Sign CRISPR/Cas9 License Agreement". Dublin & Barcelona. 2021-02-16
Centessa Pharmaceuticals Ltd.. (2/16/21). "Press Release: Centessa Pharmaceuticals Launches with $250 Million Series A Financing and Unveils a New Kind of Pharmaceutical R&D Model". Cambridge, MA & London. 2021-02-16
Immunocore Holdings plc. (2/16/21). "Press Release: Immunocore Announces Key Appointments to Management and Board". Oxfordshire & Conshohocken, PA. 2021-02-16
Discovery Park Ltd.. (2/15/21). "Press Release: Fast Growing Food Safety Testing Firm Curtis Analytics Relocates to Discovery Park". Sandwich, Kent. 2021-02-15
Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma Establishes Center of Excellence for Cell and Gene Therapy in the UK". Laupheim & Stevenage. 2021-02-11
Quell Therapeutics Ltd.. (2/11/21). "Press Release: Quell Therapeutics Expands Series A Financing to $84 Million". London. 2021-02-11
Rentschler Biopharma SE. (2/11/21). "Press Release: Rentschler Biopharma to Build New Cell and Gene Therapy Capabilities in the UK". London & Laupheim. 2021-02-11
SpyBiotech Ltd.. (2/10/21). "Press Release: SpyBiotech Raises $32.5M in Series A funding and Appoints Lutz B. Giebel as Chairman". Oxford. 2021-02-10
Immunocore Holdings plc. (2/9/21). "Press Release: Immunocore Announces Closing of $312.1 Million Aggregate Financing, Consisting of $297.1 Million Initial Public Offering, Full Exercise of Option to Purchase Additional ADSs and $15.0 Million Concurrent 2021-02-09
Secarna Pharmaceuticals GmbH & Co. KG. (2/4/21). "Press Release: Secarna Pharmaceuticals Appoints Alexander Gebauer, MD, PhD as CEO and Managing Director". Munich/Martinsried. 2021-02-04
PepGen Ltd.. (2/4/21). "Press Release: PepGen Announces Appointment of James McArthur, Ph.D., as President and Chief Executive Officer". Boston, MA & Oxford. 2021-02-04
Abingworth LLP. (2/3/21). "Press Release: Abingworth Raises $465m for New Life Sciences Fund Abingworth Bioventures 8". London. 2021-02-03
GlaxoSmithKline plc. (2/3/21). "Press Release: GSK and CureVac to Develop Next Generation mRNA COVID-19 Vaccines". London, Tübingen & Boston, MA. 2021-02-03
Almirall S.A.. (2/3/21). "Press Release: Almirall Announces Gianfranco Nazzi as New CEO". 2021-02-03
Jazz Pharmaceuticals plc. (2/3/21). "Press Release: Jazz Pharmaceuticals to Acquire GW Pharmaceuticals plc, Creating an Innovative, High-Growth, Global Biopharma Leader". Dublin & London. 2021-02-03
BioPartner UK. (2/2/21). "Press Release: BioPartner Appoints Paul Clewlow as New Advisory Board Member". 2021-02-02
Cytiva. (2/1/21). "Press Release: Cytiva Acquires Vanrx Pharmasystems, Canadian Aseptic Filling Innovator". Amersham. 2021-02-01
Horizon Therapeutics plc. (2/1/21). "Press Release: Horizon Therapeutics plc to Acquire Viela Bio, Inc. to Significantly Expand Development Pipeline and Grow Rare Disease Medicine Portfolio". Dublin & Gaithersburg, MD. 2021-02-01
Exact Therapeutics AS. (1/29/21). "Press Release: Exact Therapeutics Announces Change of CFO with Departure of Stig Jarle Pettersen at the End of His Contracted Period". Oslo & London. 2021-01-29
Piper Sandler Companies. (1/28/21). "Press Release: Piper Sandler Expands European Healthcare Investment Banking with the Hiring of Vincenzo di Nicola". New York, NY. 2021-01-28
Avacta Group plc. (1/28/21). "Press Release: Avacta Announces Collaboration Agreement with Bruker". Cambridge, Wetherby & Billerica, MA. 2021-01-28
Exact Therapeutics AS. (1/26/21). "Press Release: Exact Therapeutics Announces Appointment of Dr Hilary McElwaine-Johnn as Chief Medical Officer and Opening of London Office". Oslo & London. 2021-01-26
Minoryx Therapeutics S.L.. (1/26/21). "Press Release: Minoryx Presents Topline Results from Phase 2/3 »ADVANCE« Study Demonstrating Significant Clinical Benefit of Leriglitazone in Adrenomyeloneuropathy (AMN)". Mataró, Barcelona. 2021-01-26
MiNA Therapeutics Ltd.. (1/21/21). "Press Release: Servier and MiNA Therapeutics Enter Collaboration in Neurological Diseases". Paris & London. 2021-01-21
BiondVax Pharmaceuticals Ltd.. (1/21/21). "Press Release: BiondVax Announces Appointment of Amir Reichman as New CEO". Jerusalem. 2021-01-21
Life Sciences Partners (LSP). (1/20/21). "Press Release: LSP Leads EUR 21 Million Series B Funding Round in Neurent Medical". Amsterdam. 2021-01-20
Slate Bio, Inc.. (1/19/21). "Press Release: Slate Bio Launches with Seed Financing to Develop Next Generation IL-2 Therapies". Charlottesville, VA. 2021-01-19
ConserV Bioscience Ltd.. (1/19/21). "Press Release: ConserV Bioscience and Lawrence Livermore National Laboratory to Collaborate on Development of Broad-spectrum Coronavirus Vaccine". London & Livermore, CA. 2021-01-19
Lonza Group AG. (1/19/21). "Press Release: NextPharma Set to Acquire Two Lonza Sites Specialized in Lipid Oral Dosage Forms". Basel & London. 2021-01-19
Cognate Bioservices, Inc.. (1/14/21). "Press Release: Cognate BioServices Announces Major Expansion of Manufacturing Facilities in US and Europe". Memphis, TN. 2021-01-14
IO Biotech ApS. (1/13/21). "Press Release: IO Biotech Completes Oversubscribed EUR 127 Million Series B Financing to Accelerate Clinical Programs in Oncology". Copenhagen. 2021-01-13
Boehringer Ingelheim. (1/12/21). "Press Release: Boehringer Ingelheim and Enara Bio Enter Strategic Collaboration and Licensing Agreement to Discover Novel Shared Antigens for Cancer Immunotherapies". Ingelheim, Oxford & London. 2021-01-12
Creoptix AG. (1/12/21). "Press Release: Domainex Invests in the Creoptix WAVEdelta to Strengthen Its Fragment-based Drug Discovery Platform. Strong Partnership Ahead". Wädenswil & Saffron Walden. 2021-01-12
Life Sciences Partners (LSP). (1/12/21). "Press Release: LSP and Philip Scheltens Launch New, Unique Fund to Fight Dementia". Amsterdam. 2021-01-12
Affimed N.V.. (1/11/21). "Press Release: Affimed Announces €25 Million Debt Financing Agreement with Silicon Valley Bank". Heidelberg. 2021-01-11
Sanofi S.A.. (1/11/21). "Press Release: Sanofi to Acquire Kymab, Adding KY1005 to Its Pipeline, a Human Monoclonal Antibody Targeting Key Immune System Regulator OX40L". Paris & Cambridge. 2021-01-11
Novartis AG. (1/11/21). "Press Release: Novartis Expands Oncology Pipeline with In-licensing of Tislelizumab from BeiGene". Basel. 2021-01-11
Immunocore Ltd.. (1/11/21). "Press Release: Immunocore Announces Closing of $75.0 Million Series C Round". Oxfordshire, Conshohocken, PA & Rockville, MD. 2021-01-11
Qiagen N.V.. (1/7/21). "Press Release: Qiagen Announces Global Distribution Agreement for the COSMIC Database from the Wellcome Sanger Institute". Redwood City, CA & Hilden. 2021-01-07
BioGeneration Ventures B.V.. (1/7/21). "Press Release: BioGeneration Ventures BGV IV Fund Closes at €140 Million". Naarden. 2021-01-07
Advicenne S.A.. (1/7/21). "Press Release: Advicenne Announces the Appointment of Peter Meeus as Chief Executive Officer". Paris. 2021-01-07
Merus N.V.. (1/7/21). "Press Release: Merus Granted FDA Fast Track Designation of Zenocutuzumab for the Treatment of Patients with Neuregulin 1 Fusion Cancers". Utrecht & Cambridge, MA. 2021-01-07
PerkinElmer, Inc.. (1/7/21). "Press Release: PerkinElmer to Acquire Oxford Immunotec Global plc". Waltham, MA & London. 2021-01-07
Moderna, Inc.. (1/6/21). "Press Release: European Commission Authorizes COVID-19 Vaccine Moderna in Europe". Cambridge, MA. 2021-01-06
Satorius AG. (1/6/21). "Press Release: Sartorius to Acquire Novasep’s Chromatography Process Equipment Division". Göttingen. 2021-01-06
Gilead Sciences, Inc.. (1/6/21). "Press Release: Kite and Oxford BioTherapeutics Establish Cell Therapy Research Collaboration in Blood Cancers and Solid Tumors". Santa Monica, CA, Oxford & San Jose, CA. 2021-01-06
MiNA Therapeutics Ltd.. (1/5/21). "Press Release: MiNA Therapeutics Appoints Robin Wright as Chief Financial Officer". London. 2021-01-05
University of Birmingham. (1/5/21). "Press Release: New COVID-19 Test Gives Positive Result in Just a Few Minutes". 2021-01-05
Novacyt S.A.. (1/5/21). "Press Release: Executive Management and Proposed Board Changes". Paris & Camberley. 2021-01-05
Faron Pharmaceuticals Oy. (1/4/21). "Press Release: Faron to Present at H.C. Wainwright BioConnect". Turku. 2021-01-04
Clinigen Group plc. (1/4/21). "Press Release: Clinigen Appoints Sam Herbert as Chief Operating Officer". 2021-01-04
AstraZeneca plc. (12/30/20). "Press Release: AstraZeneca’s COVID-19 Vaccine Authorised for Emergency Supply in the UK". 2020-12-30
Peptilogics. (12/21/20). "Press Release: Peptilogics Closes $35.4 Million Series B Financing to Further Advance Proprietary Computational Peptide Drug Design and Discovery Platform". Pittsburgh, PA. 2020-12-21
Uniqure N.V.. (12/21/20). "Press Release: uniQure Announces Clinical Update on Hemophilia B Gene Therapy Program". Lexington, MA & Amsterdam. 2020-12-21
NuCana plc. (12/21/20). "Press Release: NuCana Appoints Andrew Kay as Board Chairman". Edinburgh. 2020-12-21
GlaxoSmithKline plc. (12/18/20). "Press Release: GSK and Ahren Announce Co-Led Series A Investment in Adrestia, and Multi-Project Discovery Collaboration with Each of the Five Projects Eligible To Receive Up To $230M (£172M) in Post Option Milestones". L 2020-12-18
InnoSkel S.A.S.. (12/14/20). "Press Release: InnoSkel Launches with €20 Million Series A Financing". Copenhagen. 2020-12-14
AstraZeneca plc. (12/12/20). "Press Release: AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development [Not for any jurisdicition where violation of relevant laws]". 2020-12-12
Nouscom AG. (12/11/20). "Press Release: Nouscom Appoints Göran Ando MD as Chairman and Richard Davis PhD as Chief Business Officer". Basel. 2020-12-11
NanoSyrinx Ltd.. (12/10/20). "Press Release: NanoSyrinx Strengthens Board with Appointment of Dr Jane Dancer as Non-Executive Director". Coventry. 2020-12-10
[iito] Business Intelligence. (12/10/20). "The [LSE] Newsletter Is Out! Hand-picked & Manually Edited European and Israeli Life Science Business News". Bremen. 2020-12-10
Enara Bio Ltd.. (12/9/20). "Press Release: Enara Bio Relocates to The Oxford Science Park’s Newest Facility to Expand R&D Capabilities in the Search for Novel Vancer Immunotherapies". Oxford & London. 2020-12-09
PepGen Ltd.. (12/9/20). "Press Release: PepGen Raises $45M Series A". Boston, MA & Oxford. 2020-12-09
Forbion Capital Partners. (12/8/20). "Press Release: Forbion Secures EUR 460 Million for Oversubscribed Fifth Fund". Naarden & Munich. 2020-12-08
Achilles Therapeutics Ltd.. (12/7/20). "Press Release: Achilles Therapeutics Appoints Lee M. Stern as VP, IR & External Communications". Stevenage. 2020-12-07
CureVac N.V.. (12/4/20). "Press Release: CureVac Appoints Antony Blanc as Chief Business Officer and Chief Commercial Officer". Tübingen & Boston, MA. 2020-12-04
Transgene S.A.. (12/3/20). "Press Release: Transgene Appoints Hedi Ben Brahim as Chairman and Chief Executive Officer". Strasbourg. 2020-12-03
University of Edinburgh, Centre for Regenerative Medicine. (12/2/20). "Press Release: Cell Therapy Spinout Targets Liver Repair Treatment". 2020-12-02
Syncona Ltd.. (12/2/20). "Press Release: Resolution Therapeutics Announces a £26.6m Series A Financing from Syncona Ltd". 2020-12-02
BioInnovation Institute (BII). (12/2/20). "Press Release: BioInnovation Institute Takes in New Cohort of Promising Early-stage Innovations". Copenhagen. 2020-12-02
ERS Genomics Ltd.. (12/1/20). "Press Release: Vivlion GmbH Signs Worldwide License Agreement With ERS Genomics for CRISPR/Cas9 Patent Portfolio". Dublin & Frankfurt/M.. 2020-12-01
Salesforce.com Inc.. (12/1/20). "Press Release: Salesforce Signs Definitive Agreement to Acquire Slack". San Francisco, CA. 2020-12-01
Achilles Therapeutics Ltd.. (12/1/20). "Press Release: Achilles Therapeutics Appoints Robert Coutts as Chief Financial Officer". Stevenage. 2020-12-01
[iito] Business Intelligence. (11/30/20). "The [LSG] Newsletter Is Out! Hand-picked & Manually Edited DACH Region Life Science Business News from Germany, Austria & Switzerland". Bremen. 2020-11-30
BioNTech SE. (11/25/20). "Press Release: BioNTech and InstaDeep Announce Strategic Collaboration and Form AI Innovation Lab to Develop Novel Immunotherapies". Mainz & London. 2020-11-25
LGC. (11/25/20). "Press Release: LGC Offers Regulated Bioanalysis on the Sciex TripleTOF 6600 High-Resolution Mass Spectrometry Platform". London. 2020-11-25
ATAI Life Sciences AG. (11/23/20). "Press Release: ATAI Life Sciences Announces Closing of $125 Million Series C Financing Round". New York, NY. 2020-11-23
Catamaran Bio, Inc.. (11/23/20). "Press Release: Catamaran Bio Launches with $42 Million Financing to Develop Off-the-Shelf CAR-NK Cell Therapies to Treat Solid Tumors". Cambridge, MA. 2020-11-23
Omnix Medical. (11/20/20). "Press Release: Omnix Medical Announces Successful $8.5 Million Funding Round". 2020-11-20
SynOx Therapeutics Ltd.. (11/19/20). "Press Release: SynOx Therapeutics Raises €37M in Series A Financing. HealthCap and Medicxi Co-lead, Joined by Forbion and Gimv". Dublin. 2020-11-19
SR One Capital Management. (11/19/20). "Press Release: SR One Completes Spin-out from GSK and Closes First Fund at $500 Million". San Francisco, CA & London. 2020-11-19
MeiraGTx Holdings plc. (11/19/20). "Press Release: MeiraGTx Announces Pricing of Public Offering of Ordinary Shares". London & New York, NY. 2020-11-19
Achilles Therapeutics Ltd.. (11/19/20). "Press Release: Achilles Therapeutics Raises £52.7 Million in an Oversubscribed Series C Financing to Further Advance the Development of Personalised T cell Therapies to Treat Solid Tumours". Stevenage. 2020-11-19
Emergex Vaccines Holding Ltd.. (11/18/20). "Press Release: Emergex Vaccines Raises US$11 Million to Advance Pipeline of Synthetic T-Cell Vaccines for Infectious Diseases". Abingdon. 2020-11-18
Evotec SE. (11/17/20). "Press Release: Evotec and Storm Therapeutics Leverage INDiGO Platform to Progress Oncology Project towards Clinical Studies". Hamburg. 2020-11-17
Myricx Pharma Ltd.. (11/16/20). "Press Release: Myricx Pharma Launches with £4.5M Financing to Progress its Novel NMT inhibitors in Cancer". Stevenage. 2020-11-16
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25  next pagenext page



Advertisement

Picture ConsulTech GmbH GDPR-compliant E-Col Cloud Document Management 650x80px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

Picture [iito] Back into Ad 650x80px

» top